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ipid movement between organelles is a critical com-
ponent of eukaryotic membrane homeostasis. Niemann
Pick type C (NP-C) disease is a fatal neurodegenerative
disorder typiﬁed by lysosomal accumulation of cholesterol
and sphingolipids. Expression of yeast 
 
NP-C–related gene 1
 
(
 
NCR1
 
), the orthologue of the human 
 
NP-C gene 1
 
 (
 
NPC1
 
)
defective in the disease, in Chinese hamster ovary 
 
NPC1
 
mutant cells suppressed lipid accumulation. Deletion of
 
NCR1
 
, encoding a transmembrane glycoprotein predomi-
nantly residing in the vacuole of normal yeast, gave no
phenotype. However, a dominant mutation in the putative
L
 
sterol-sensing domain of Ncr1p conferred temperature and
polyene antibiotic sensitivity without changes in sterol
metabolism. Instead, the mutant cells were resistant to
inhibitors of sphingolipid biosynthesis and super sensitive
to sphingosine and C2-ceramide. Moreover, plasma mem-
brane sphingolipids accumulated and redistributed to the
vacuole and other subcellular membranes of the mutant
cells. We propose that the primordial function of these
proteins is to recycle sphingolipids and that defects in this
process in higher eukaryotes secondarily result in choles-
terol accumulation.
 
Introduction
 
The function of eukaryotic membranes reflects their lipid
composition as much as that of proteins, and yet the mecha-
nisms by which lipid partitioning is maintained are largely
unknown. Niemann Pick type C (NP-C) disease is a neuro-
degenerative lipid storage disorder, the accepted biochemical
hallmark of which is the lysosomal accumulation of low
density lipoprotein (LDL)–derived unesterified cholesterol.
Consequently, the reactions responsible for sterol biosynthesis,
uptake, and esterification are misregulated (Pentchev et al.,
1997). Although the defect in cholesterol egress from the
endosomal–lysosomal (E–L) system is the predominant cellular
phenotype, NP-C disease is further typified by the subcellular
accumulation of complex glycosphingolipids (Vanier, 1999).
Moreover, fibroblasts from a “variant” subgroup of NP-C
individuals with profound neurodysfunction exhibit severe
sphingolipid transport aberrancies but modest cholesterol
mislocalization (Sun et al., 2001). Subcellular protein transport
does not appear to be altered in 
 
NP-C gene 1
 
 (
 
NPC1
 
)–defective
cells; however, markers of endocytosis exhibit retarded trans-
port to extralysosomal sites (Neufeld et al., 1999).
A positional cloning approach identified the 
 
NPC1
 
 gene as
defective in 95% of patients with NP-C disease (Carstea et al.,
1997). 
 
NPC1
 
 predicts a glycosylated, transmembrane protein
with a similarity to the morphogen receptor Patched (Ptc,
23% identity) and the sterol regulatory element-binding protein
(SREBP) cleavage-activating protein (SCAP), a protein integral
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to sterol and fatty acid homeostasis (26% identity over 190
residues; Fig. 1). The latter conservation corresponds to a pu-
tative sterol-sensing domain (SSD). 
 
NPC1
 
 is ubiquitously
and constitutively expressed in mammalian tissues and is con-
served from yeast to humans (Loftus et al., 1997). In contrast,
many aspects of receptor-mediated uptake of sterol are absent
over the same period of evolution, suggesting a primordial
function of the Npc1 protein family that predates exogenous
sterol transport. We demonstrate that the 
 
NP-C–related gene
1
 
 (
 
NCR1
 
), the yeast orthologue of mammalian 
 
NPC1
 
, per-
forms a conserved function that is distinct from trafficking of
sterol. We show that in mammalian cells the proteins are in-
terchangeable with respect to cholesterol and ganglioside
transport, and yet a null mutation in yeast 
 
NCR1
 
 has no ste-
rol-related phenotype. A dominant mutation in the SSD of
yeast 
 
NCR1
 
 confers pleiotropic phenotypes consistent with
altered sphingolipid transport. We propose that in this ances-
tral eukaryote, the role of NPC1-like proteins is to recycle
sphingolipids and that in multicellular organisms, one conse-
quence of this is transport of cholesterol.
 
Results
 
Yeast 
 
NCR1
 
, an orthologue of human 
 
NPC1
 
The predominant sterol of 
 
Saccharomyces cerevisiae
 
 is ergos-
terol, which is synthesized, esterified, used, and regulated in
a similar manner to cholesterol in mammals (Sturley, 2000).
Subcellular sterol transport may also be conserved between
yeast and mammalian cells; Ncr1p (YPL006w) is an unchar-
acterized 1,170-residue transmembrane protein with a signal
peptide, eight N-glycosylation sites, and 35% identity to the
human Npc1 protein. As for Npc1p, Ncr1p is structurally
Figure 1. Sequence comparisons of human Npc1 and yeast Ncr1p. 
(A) Conserved domains in NPC1 and Ncr1p. In addition to the NPC 
domain that distinguishes the NPC1 gene family, Ncr1p retains a 
putative sterol-sensing domain (SSD) and several regions of similarity 
to the morphogen receptor, Patched (Patched homology domain, 
PHD). (B) The putative SSD of NPC1, Ncr1p, and SCAP. Residues 
599–789 of human NPC1, 538–721 of yeast Ncr1p, and 264–444 
of human SCAP are aligned. Sequence identity is indicated by the 
vertical bar and similarity by colons and periods. Across this region 
the NPC1 and Ncr1p sequences are 43% identical. The NCR1Y571C, 
NCR1Y718D, and NCR1Y718N variants are indicated.
Figure 2. Expression of yeast NCR1 restores lipid trafficking in NPC1 
mutant mammalian cells. CHO cell line CT60 was transiently 
transfected with a human NPC1–EGFP fusion or cotransfected with 
pEGFP and pCR3.1 (vector), pCR3.1-NCR1 (NCR1), or pCR3.1–
NCR1-Cterm (NCR1-Cterm). The arrows indicate transfected cells 
based on fluorescence conferred by the pEGFP vector or the 
NPC1–EGFP fusion. Representative images are shown. (A) Cells 
were preincubated with LDLs and stained for cholesterol with 
filipin and imaged for GFPs. (B) Transfected cells were stained 
with fluorescent subunit B of cholera toxin (CTx-B) to detect the 
ganglioside GM1 and imaged for GFPs. 
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similar to Ptc and the SSD of SCAP (Fig. 1), and further-
more, identical to the normal 
 
NPC1
 
 allele at many residues
implicated in NP-C disease (Greer et al., 1999; Ribeiro et
al., 2001). These alleles include G
 
897
 
 and I
 
972
 
 in Ncr1p, cor-
responding to two common NP-C disease alleles (G
 
992
 
W
and I
 
1061
 
T, respectively). Overall, the molecules are compel-
lingly similar.
 
Expression of yeast 
 
NCR1
 
 complements loss of NPC1
 
To test the functional equivalence of the yeast and human
proteins, we expressed 
 
NCR1
 
 in CHO CT60 and NPC1-
trap cells lacking Npc1 (Cruz et al., 2000; Higaki et al.,
2001). Yeast proteins lack targeting information for mamma-
lian endosomes. Because Npc1p localization, which is medi-
ated by COOH-terminal motifs is required for full comple-
mentation (Watari et al., 1999; Ioannou, 2000), we fused the
last 64 residues of human NPC1 to Ncr1p (
 
NCR1-Cterm
 
).
Expression constructs for 
 
NCR1
 
 and 
 
NCR1-Cterm
 
 were
transfected into the CHO cells, and sterol transport was as-
sessed by filipin staining and fluorescence microscopy. Ex-
pression of 
 
NCR1-Cterm
 
 restored cholesterol clearance to lev-
els indistinguishable from cells expressing human 
 
NPC1
 
 (Fig.
2 and Table I). A significant decrease in E–L filipin staining
was also observed upon expression of 
 
NCR1
 
. Although fewer
filipin negative cells were observed, most transfected cells dis-
played “partial” clearance of cholesterol. This diminished
suppression likely reflects mislocalization of the native yeast
protein; a GFP fusion with Ncr1p localizes to the early endo-
some, whereas NCR1-Cterm–GFP was detected in the late
endosomal compartment (unpublished data).
The subcellular accumulation of sphingolipids, particu-
larly gangliosides, is another characteristic of the NP-C syn-
drome, and in the case of GM1 has been observed in NPC1-
deficient CHO cells (Sugimoto et al., 2001). Expression of
 
NCR1-Cterm
 
 or human 
 
NPC1
 
 reversed the accumulation of
GM1 in the E–L compartment of transfected CT60 cells as
detected by fluorescent cholera toxin (subunit B) binding as-
says (Fig. 2 B). Thus, when provided with the correct local-
ization motif, the yeast and human proteins function inter-
changeably, suggesting a conserved activity despite several
billion years of divergence.
 
Null mutations in yeast 
 
NCR1
 
 have no effect on 
sterol metabolism
 
In mammalian cells lacking NPC1, exogenous sterol is se-
questered from the esterification reaction and sterol biosyn-
thesis is misregulated. During anaerobic growth (Gollub et
al., 1974) or in 
 
upc2-1
 
 mutants (Lewis et al., 1988), sterol is
absorbed by yeast in an ABC-transporter–dependent process
(Wilcox et al., 2002) and esterified by the acylCoA choles-
 
Table I.  
 
Restoration of cholesterol transport in 
 
npc1
 
-deficient 
CHO cells by expression of yeast 
 
NCR1
 
Percentage of corrected cells per GFP-positive cells
Partial Complete
DNA CT60 NPC1-trap CT60 NPC1-trap
 
vector 6.7 
 
  
 
2.1 3.0 
 
  
 
1.7 0.7 
 
 
 
 0.5 2.3 
 
 
 
 1.5
 
NCR1
 
18.7 
 
 
 
 4.5
 
a
 
17.3 
 
 
 
 0.6
 
a
 
17.0 
 
 
 
 2.6
 
a
 
15.3 
 
 
 
 2.5
 
a
 
NCR1-Cterm
 
14.3 
 
 
 
 2.5 10.7 
 
 
 
 4.0 56.7 
 
 
 
 2.1
 
b
 
61.3 
 
 
 
 5.1
 
b
 
CHO cells were cotransfected with pEGFP and pCR3.1 (vector), pCR3.1-NCR1
(
 
NCR1
 
), or pCR3.1-NCR1-Cterm (
 
NCR1-Cterm
 
),  incubated in the presence
of low density lipoproteins, stained with filipin to detect unesterified
cholesterol, and imaged for GFP.  Partial restoration was defined as the
reduction of intensity or the number of fluorescent vesicles compared with
vector control.  Cells lacking filipin fluorescence were classified as completely
corrected.  Means 
 
 
 
 SEM from three independent experiments.
 
a
 
Significant differences from vector transfection, P 
 
 
 
 0.01. 
 
b
 
Significant differences from vector transfection, P 
 
 
 
 0.001.
 
Table II.  
 
Phenotypic characterization of 
 
ncr1
 
 mutant strains
Genotypes
Phenotypes tested
 
NCR1
 
(normal)
 
ncr1
 
 
 
Y
 
718
 
DY
 
718
 
NY
 
571
 
C
 
Sterol synthesis ([
 
3
 
H]acetate),
(P vs. 
 
NCR1
 
)
18.2 
 
 
 
 2.9 19.7 
 
 
 
 1.2
(0.4)
13.2 
 
 
 
 2.3
(0.07)
13.2   1.8
(0.07)
16.2   1.6
(0.37)
Sterol esterification
([
3H]oleate), (P vs. NCR1)
11.0   2.8 11.9   2.4
( 0.05)
11.9   0.9
( 0.05)
10.5   2.7
( 0.05)
10.7   1.7
( 0.05)
Exogenous sterol esterification
[
14C]cholesterol, (P vs. NCR1)
74.3    2.0 69.2   6.3
( 0.05)
72.2   3.8
( 0.05)
77.9   3.6
( 0.05)
78.1   0.8
( 0.05)
30 C (2% dextrose)              
38 C (2% dextrose)       –      
Anaerobiosis              
Nystatin (5  g/ml)       –      
Ethanol (3%)       –      
Acetate (2%)       –      
Sodium chloride (0.75 M)       –      
Sorbitol (1.0 M)              
Calcium chloride (0.8 M)              
Hydroxyurea (40 mM)              
Yeast strains with the missense mutations Y718D, Y718N, and Y571C in the SSD of NCR (Fig. 1 B) were assessed for growth or metabolic incorporation (percent
incorporation   SEM) under the conditions described.  The growth of the normal strain is considered    and the growth of the other strains is expressed
relative to that scale.550 The Journal of Cell Biology | Volume 164, Number 4, 2004
terol acyltransferase orthologues (Yang et al., 1996). Dele-
tion of NCR1 had no effect on acetate incorporation into
sterols, oleate incorporation into steryl esters, anaerobic via-
bility, or esterification of exogenous [
14C]cholesterol (Table
II). Cell sterol composition can be exaggerated by deletion
of ERG6 (C-24 sterol methyl transferase; Gaber et al., 1989)
or ERG9 (squalene synthase; Fegueur et al., 1991) or treat-
ment with zaragozic acid, an inhibitor of squalene synthase
(Bergstrom et al., 1993). This exaggeration results in mem-
brane perturbations and, in the latter two cases, sterol auxo-
trophy; however, loss of NCR1 in these contexts had no ef-
fect on cell viability or sterol uptake (unpublished data).
In contrast to observations with NP-C mutant fibroblasts
(Fig. 2 A), the majority of sterol in ncr1  and normal yeast
strains detected by filipin fluorescence resides at the plasma
membrane (Fig. 3 A). In validation of the assay, arv1 strains
that accumulate sterols in subcellular membranes (Tinkelen-
berg et al., 2000) displayed significant subcellular filipin
staining, whereas an erg6 mutant had barely detectable plasma
membrane fluorescence. Moreover, ncr1  strains displayed
Figure 3. Sterol distribution in yeast 
NCR1 mutants. (A) Yeast strains (normal, 
ncr1 , and NCR1Y718D) were stained 
with filipin to detect ergosterol. Deletions 
in ERG6 (erg6 ) block synthesis of 
ergosterol, whereas ARV1 deletions 
(arv1 ) accumulate sterol in subcellular 
membranes. (B) Cell membrane prepara-
tions from normal and NCR1 deletion 
strains were subjected to subcellular 
fractionation, lipid extraction, and TLC analysis after [
14C]oleate or 
[
3H]acetate incorporation. Distributions of sterols relative to phospho-
lipid are given as a ratio of [
3H]acetate to [
14C]oleate. Total [
3H]acetate 
and [
14C]oleate incorporation was 3.06 and 1.79 (normal) versus 
2.77 and 1.18 (deletion)   10
5 dpm/OD
600, respectively. Fractions 
were characterized by immunoblotting with antisera to the plasma 
membrane ATPase (Pma1p, solid line, squares) and the vacuolar 
membrane H
 -ATPase (Vph1p, dashed line, diamonds), followed 
by scanning densitometry (arbitrary units, representative data).
Figure 4. NCR1 expression in yeast. (A) RNA 
hybridization of the indicated strains grown in 
YPD media at 30 C. The loading control of 28S 
ribosomal RNA is shown. No significant differences 
in NCR1 transcript levels for normal, NCR1Y718D, 
NCR1Y718N, or NCR1Y571C (not depicted) strains 
were detected. (B) Expression of Ncr1-HAp. The 
chromosomal copy of NCR1 was tagged with HA 
at the COOH terminus by homologous recombi-
nation. Duplicate membrane extracts were 
solubilized with Triton X-100, deglycosylated 
(endo-H), and resolved by SDS-PAGE and 
immunoblotting ( HA 12CA5 mAb). Molecular 
mass markers (Bio-Rad Laboratories) are shown. 
(C) Subcellular localization of Ncr1-HAp. 
Membrane preparations from cells expressing 
Ncr1-HA were fractionated by ultracentrifugation 
in Renograffin 60. Fractions 1–14 were charac-
terized by SDS-PAGE and immunoblotting with 
antibodies to Ncr1-HA (Anti-HA), the plasma 
membrane ATPase (Anti-Pma1p), and the vacuolar 
H
 -ATPase (Anti-Vph1p).Sphingolipid recycling in yeast | Malathi et al. 551
no changes in sensitivity to polyene antibiotics (e.g., nystatin)
that form lethal complexes with ergosterol. Finally, the rela-
tive distribution of sterols and phospholipids across a subcel-
lular fractionation was unchanged in ncr1  mutants (Fig. 3
B), further suggesting that membrane composition, particu-
larly with respect to sterol, was unaffected by loss of NCR1.
Normal and ncr1  strains grew comparably on a variety of
carbon sources and at different temperatures (12 , 30 , 38 ,
and 40 C). Similarly, there was no growth differential due to
supplementation with 1 M sorbitol or 0.75 M NaCl (Table
II). A transmembrane permease activity with specificity for
oleic acid and acriflavine has been suggested for Npc1p
(Davies et al., 2000). However, we could detect no defect in
uptake of [
3H]oleate or in accumulation of acriflavine in ncr1
mutants (unpublished data). In a further attempt to reveal a
phenotype due to loss of NCR1, we undertook a transcrip-
tional profiling approach. Oligonucleotide arrays (Affymet-
rix) were used to compare normal and ncr1  strains. Consis-
tent with the redundancy of NCR1, there were no significant
(i.e., greater than twofold) transcriptional differences between
these strains (unpublished data). In summation, the deletion
of NCR1 had no detectable physiological consequences.
Expression and localization of Ncr1p
The NCR1 gene is transcribed (Fig. 4 A) and expressed in
normal strains and growth conditions as evidenced by tagging
the endogenous protein with the HA epitope NCR1-HA. The
biological activity of this allele was confirmed in the NPC1
mutant CHO cells (unpublished data). Ncr1-HAp was de-
tected as a membrane-associated, endoglycosidase H-sensitive
glycoprotein ( 130 kD; Fig. 4 B), indicating its passage
through the ER. In a further example of concordance between
the yeast and human proteins, Ncr1-HAp cofractionated pre-
dominantly with normal yeast vacuoles, the equivalent or-
ganelle to the E–L system of mammalian cells (Fig. 4 C). Fur-
thermore, a GFP-Ncr1 fusion protein localizes to the vacuolar
membrane (Huh et al., 2003; unpublished data).
A dominant mutation in the SSD of yeast NCR1
Ncr1p is biologically active when expressed in mammalian
cells, and yet loss of Ncr1p is of no apparent consequence in
yeast. To bypass this redundancy, we introduced mutations
in NCR1 (Fig. 1 B) analogous to dominant mutations in the
SSD of SCAP (Nohturfft et al., 1998). The presence of as-
paragine instead of aspartic acid at residue 443 in SCAP
confers sterol-resistant SREBP cleavage; thus, we mutated
the analogous residue (Tyr718) of Ncr1p to either aspar-
tic acid (NCR1Y718D) or asparagine (NCR1Y718N). In addi-
tion, we changed an invariant tyrosine of the Ncr1p SSD
(Tyr571) to cysteine (NCR1Y571C). The mutations were in-
troduced at the NCR1 locus by homologous recombination
and did not affect NCR1 transcript levels (Fig. 4 A).
Because the NCR1Y571C, NCR1Y718D, and NCR1Y718N
mutations reside in a putative SSD, we anticipated an alter-
Figure 5. Sphingolipid phenotypes in NCR1 mutants. (A) Fivefold dilutions 
of strains of the indicated genotypes were plated to the media shown and 
incubated at 30 or 38 C. (B) Haploid yeast of the indicated genotype were 
transformed with control or NCR1 expression plasmids, serially diluted, and 
plated at 30 and 38 C. (C) Growth of strains of the indicated genotypes in response to sphingosine or ABA were derived by continuous analysis 
of culture absorbance (600 nm). (D) Synthesis of ceramide and IPC after metabolic incorporation of [
3H]DHS (2 h) in the presence of ABA. 
Sphingolipids were extracted and analyzed by TLC and radio-image scanning. The percent total incorporation into all lipids are shown. 
Means   SEM; *, P   0.01, relative to previous concentration of ABA. Absence of error bars indicates too small for scale.552 The Journal of Cell Biology | Volume 164, Number 4, 2004
ation in sterol metabolism. NCR1Y718D strains, unlike the
others, were hypersensitive to nystatin, suggestive of per-
turbed plasma membrane properties (Fig. 5 A). However,
anaerobic growth, an indicator of exogenous sterol trans-
port, was unaltered relative to aerobic growth (Table II).
Furthermore, sterol synthesis, esterification (Table II), and
localization (Fig. 3 A; and see Fig. 7 C) were not signifi-
cantly different in these strains compared with normal
strains. The NCR1Y718D allele conferred poor growth at
30 C, inviability at 38 C (Fig. 5 A), and salt sensitivity and
poor growth on carbon sources such as acetate and ethanol
(Table II). The NCR1Y718N and NCR1Y571C, strains were
modestly impaired at elevated temperatures (Fig. 5 A), but
were otherwise indistinguishable from normal strains. The
NCR1Y718D strains were not uniformly sick; responses to
sorbitol, calcium, hydroxyurea, and low pH were indistin-
guishable from growth on YPD at 30 C (Table II).
Yeast strains with the NCR1Y718D mutation exhibit
pleiotropic phenotypes, whereas the ncr1  strain showed
no defects, predicting that this variant would act as a domi-
nant allele. Normal, ncr1 , and NCR1Y718D strains were
transformed with vector control or a plasmid carrying
NCR1. NCR1 expression was confirmed by RT-PCR assays
(not depicted) but failed to rescue inviability at 38 C of the
NCR1Y718D strains (Fig. 5 B). In addition, heterozygous
NCR1/NCR1Y718D diploids retain the temperature sensitiv-
ity of the NCR1Y718D allele, further indicating dominant in-
heritance (unpublished data).
The NCR1Y718D allele alters sphingolipid metabolism
NP-C disease is characterized by sphingolipid accumulation.
Furthermore, the sensitivity of yeast to temperature, high
salt, or polyenes can result from modulations in sphingolip-
ids (Dickson and Lester, 2002). Thus, in the absence of a
sterol-related phenotype, we questioned whether or not
sphingolipid metabolism was disturbed by mutations in NCR1.
In S. cerevisiae, ceramide is synthesized from phytosphin-
gosine and is the precursor for synthesis of inositolphos-
phorylceramide (IPC), mannosyl-IPC (MIPC), and man-
nosyl-di-IPC (M(IP)2C). These complex sphingolipids are
analogous to mammalian sphingolipids in that they associate
with sterols in the plasma membrane and perform a critical role
in membrane function (Dickson and Lester, 2002). Normal
yeast strains are sensitive to sphingosine and C2-ceramide
(Nickels and Broach, 1996; Chung et al., 2001). The
NCR1Y718D mutant strain was super sensitive to 10  M
C2-ceramide (Fig. 5 A) and 5  M sphingosine (Fig. 5 C)
compared with the other strains. This phenotype was evi-
dent as a prolonged lag phase, which is consistent with re-
tarded nutrient uptake, a trait common to alterations in
sphingolipids (Chung et al., 2001).
Changes in sphingolipid status can also be monitored us-
ing antifungals such as aureobasidin A (ABA), which blocks
synthesis of IPC causing ceramide accumulation and invia-
bility (Nagiec et al., 1997). NCR1Y718D strains were resis-
tant to 500 ng/ml ABA, whereas normal and ncr1  strains
were sensitive (Fig. 5 C). ABA resistance was associated with
increased incorporation of [
3H]dihydrosphingosine (DHS)
into IPC at the expense of ceramide over a range of drug
concentrations (Fig. 5 D), which is consistent with increased
flux through the sphingolipid biosynthetic pathway of
NCR1Y718D strains.
The sensitivity of the NCR1Y718D strain to sphingosine
and C2-ceramide, and resistance to ABA, led us to assess
metabolic incorporation of [
3H]DHS into sphingolipids in
the mutant strains over a 2-h labeling period (Fig. 6). The
Figure 6. Sphingolipid metabolism in NCR1 mutants. (A) The 
sphingolipid biosynthetic pathway and the metabolism of [
3H]DHS 
in normal and NCR1Y718D cells. Genes for the biosynthesis of 
ceramide, IPC, MIPC, and M(IP)2C are indicated. Long-chain fatty 
acylCoA (LCFA-CoA) is an essential substrate for the synthesis of 
ceramide. Sphingolipids were extracted from the indicated strains 
grown in the presence of [
3H]DHS for 2 h and analyzed by TLC 
and radio-image scanning. The percent incorporation into all lipids 
are shown for sphingolipids. Means   SEM; *, P   0.01, relative 
to normal cells. Total incorporation of [
3H]DHS for normal and 
NCR1Y718D strains was 1.43 and 1.32   10
6 cpm/mg dry weight, 
respectively. (B) Quantification of RNA hybridization analysis for 
genes determining the synthesis of MIPC (CSG1 and CSG2). RNA 
was extracted, resolved, transferred to nitrocellulose membranes by 
conventional methods, hybridized with CSG1 or CSG2 probes, and 
analyzed using a phosphorimager (arbitrary units, means   SEM). 
Deletion strains csg1  and csg2 , respectively, for CSG1 and CSG2 
acted as hybridization controls. Actin message levels were comparable 
between strains (not depicted). (C) The stress induction of ceramide 
synthesis in NCR1 mutants. Cultures of the indicated genotype were 
grown to exponential phase, split, and grown for a further 2 h in the 
presence of [
3H]DHS at 30 or 38 C. Incorporation of label was 
normalized to total incorporation into all lipids, which was equivalent 
at both temperatures (e.g., for normal strains, 2.53 and 2.19   10
6, 
cpm at 30 and 38 C, respectively). *, P   0.01.Sphingolipid recycling in yeast | Malathi et al. 553
levels of ceramide were comparable between the strains.
However,  NCR1Y718D strains accumulated 2.8-fold more
MIPC (23.3% vs. 8.1%, P   0.01%) and significantly less
IPC and M(IP)2C (Fig. 6 A). No changes in sphingolipids
were observed in the other NCR1 mutants (unpublished
data). Given the elevated MIPC levels in NCR1Y718D
strains, we assessed the expression of CSG1, CSG2 (encod-
ing components of MIPC synthase), and IPT1 (mediating
the synthesis of M(IP)2C). CSG2 transcript levels were ele-
vated in NCR1Y718D strains (Fig. 6 B).
Upon heat shock, yeast elevate ceramide levels (Jenkins et
al., 1997). To assess if the temperature sensitivity of the
NCR1Y718D strains was related to sphingolipid metabolism,
we monitored the changes in ceramide levels of normal,
ncr1 , and NCR1Y718D strains upon shifting to 38 C and
labeling with [
3H]DHS. Ceramide levels increased four-
fold in normal and ncr1  strains upon temperature shift,
whereas NCR1Y718D strains showed less than a twofold in-
crease (Fig. 6 C). Complex sphingolipids were not altered by
heat shock relative to growth at 30 C. The molecular mech-
anism or purpose for increased de novo synthesis of cer-
amide after heat stress is not known, however, the dimin-
ished response by the NCR1Y718D strains may explain their
compromised growth rates.
The NCR1Y718D mutation causes sphingolipid 
mislocalization
In NPC1-deficient mammalian cells, the primary defect in
sphingolipid metabolism relates to transport out of the E–L
system (Choudhury et al., 2002). To assess whether the re-
cycling of complex sphingolipids through the yeast endoso-
mal pathway might be disturbed by mutations in NCR1, we
labeled sphingolipids to steady state by incubation for 18 h
with [
3H]DHS and subjected membranes to subcellular
fractionation to separate plasma membranes from subcellu-
lar organelles (Fig. 7). Before fractionation, it is clear that in
NCR1Y718D strains MIPC accumulates at the expense of
M(IP)2C, which is consistent with diversion of the former
molecule from a biosynthetic pool (Fig. 7 A). In normal
strains, MIPC and M(IP)2C accumulate in the plasma mem-
brane (Fig. 7, fractions 8–10), colocalizing with the plasma
membrane ATPase (Pma1p). We could detect no differences
in the distribution of DHS metabolites in ncr1  strains (un-
published data). However, in the NCR1Y718D strains,
Figure 7. Subcellular distribution of lipids 
in NCR1 mutants. Lipid levels were assessed 
after metabolic labeling to steady state with 
[
3H]DHS (sphingolipids), [
14C]oleate (phos-
pholipids), or [
3H]acetate (sterols) at 30 C 
for 18 h. (A) Total cellular incorporation 
into sphingolipid pools (percentage of total 
extraction, means   SEM; *, P < 0.01 relative 
to normal). Total incorporation of [
3H]DHS 
for normal and NCR1Y718D strains was 
1.826 and 2.152   10
5 cpm per OD
600, 
respectively. (B) Cell membrane preparations 
of identical cultures to those in A were 
subjected to subcellular fractionation after 
[
3H]DHS incorporation. The distributions 
of IPC, MIPC, and M(IP)2C are presented as 
the percentage of total incorporation in 
normal (gray bars) and NCR1Y718D (black 
bars) strains (representative data). (C) Mem-
brane preparations after [
14C]oleate or 
[
3H]acetate incorporation were subjected 
to subcellular fractionation. Total [
3H]acetate 
and [
14C]oleate incorporation was 3.06 
and 1.79 (normal) versus 6.09 and 2.43 
(NCR1Y718D)   10
5 dpm/OD
600, respectively. 
The distributions of sterol and phospholipids 
are presented as the percentage of total 
incorporation in normal (gray bars) and 
NCR1Y718D (black bars) cells per fraction. 
(D) Immunoblotting of fractions with anti-
bodies to plasma membrane (Pma1p), 
dolichol phosphate mannose synthase 
(Dpm1p, ER), and vacuoles (Vph1). Peak 
fractions for these markers were coincident 
between the strains, despite apparent 
differences in protein expression.554 The Journal of Cell Biology | Volume 164, Number 4, 2004
MIPC, and to a lesser extent M(IP)2C, redistributed to sub-
cellular organelles, particularly the vacuolar compartment as
inferred by colocalization with the vacuolar H
 -ATPase
(Figs. 7, B and D, Vph1p). Indeed, if we consider fractions
4 and 5 (Fig. 7), in which Vph1p is predominant but
Pma1p or Dpm1p are low, NCR1Y718D causes a 6.5- and
7.2-fold accumulation of MIPC relative to controls. This
lipid rearrangement in the NCR1Y718D strains was specific
to complex sphingolipids. The subcellular distribution of
ceramide (Fig. 7 B), phospholipids, and sterols (Fig. 7 C)
was similar between strains.
Discussion
Niemann Pick disease type C is a neurodegenerative disor-
der with a significant defect in subcellular transport of exog-
enous sterols. However, NP-C disease is not solely a choles-
terol storage disorder, and the nature of the offending
metabolite in this syndrome is contentious, particularly in
the brain. Sterol accumulation is detectable in NPC1-defi-
cient neurons, but is not as striking as at extra-neuronal sites.
Several works in genetically modified murine models of this
disease have concluded that sterol uptake has no role in
symptom development (Xie et al., 2000a,b). In contrast, the
metabolism and transport of sphingolipids is aberrant in
most  npc1
 / cells, including neurons (Sugimoto et al.,
2001; Zervas et al., 2001a; Zhang et al., 2001). Finally,
pharmacological intervention in sphingolipid synthesis alle-
viates symptoms in animal models of NP-C disease, whereas
reductions in plasma cholesterol give no benefit (Patterson
et al., 1993; Zervas et al., 2001b).
What does the yeast system inform regarding the human
syndrome? Despite evolutionary divergence, the yeast and
mammalian proteins are functionally equivalent for sterol
and ganglioside transport in mammalian cells. However, we
failed to identify any defect in sterol metabolism conferred
by mutations in NCR1. Thus, we hypothesize that Ncr1p
performs a primordial function that underlies the sterol
transport defects associated with NP-C disease. However, a
quandary remains: what is the physiological role of this pro-
tein in yeast? The similarities of yeast Ncr1p and human
Npc1p to the SREBP cleavage-activating protein led us to
create constitutive mutations in the SSD of Ncr1p. One
such allele, NCR1Y718D, functioned as a dominant neo-
morph, its most salient phenotype being the errant subcellu-
lar accumulation of MIPC. The normal pathways of sphin-
golipid distribution (Fig. 8) commence with synthesis of
ceramide in the ER and transport to the Golgi compartment
where complex sphingolipid synthesis progresses (Funato et
al., 2002). An asymmetry is then created; MIPC and
M(IP)2C accumulate in the plasma membrane, whereas IPC
localizes to the vacuole. In the NCR1Y718D strains, the se-
questration of MIPC in the vacuole limits its retrograde
movement to the Golgi compartment  resulting in reduced
M(IP)2C synthesis. The same event likely results in up-regu-
lation of biosynthesis, in part at the level of transcription of
the CSG2 gene. This increased flux explains resistance to
pathway inhibitors, sensitivity to substrates such as C2-cer-
amide and sphingosine, and inadequate response to heat
shock in terms of ceramide accumulation.
Based on these observations, we propose that the primor-
dial role of the Npc1 protein family lies in sphingolipid recy-
cling with sterol movement as a consequence, which is con-
sistent with studies of NPC1 in mammalian cells (Coxey et
al., 1993; Sugimoto et al., 2001) and with hypotheses that
neurodegeneration in NP-C disease results from ganglioside
accumulation. There are many precedents for a link between
sphingolipid and sterol homeostasis. Multiple sphingolipid
storage disorders are associated with perturbations in choles-
terol homeostasis (Pagano et al., 2000), perhaps because the
two molecules readily form membrane microdomains (Bag-
nat et al., 2000; Simons and Ehehalt, 2002). Indeed, cho-
lesterol accumulation was strikingly reduced when NPC1
deficiency was combined with loss of the  -1-4GalNAc
transferase responsible for complex ganglioside synthesis
(Liu et al., 2000; Gondre-Lewis et al., 2003).
The SCAPs of mammals and insects via the SSDs are pro-
posed to respond to membrane perturbations rather than
changes in a specific molecule (Seegmiller et al., 2002). It is
clear that residue 443 of SCAP is a critical position in the
SSD (Nohturfft et al., 1996). Our work confirms this in a
different protein (Ncr1p) and illustrates a clear species and
molecule specificity. In mammalian SCAP, insect SCAP
(Seegmiller et al., 2002), or yeast Ncr1p, the normal residue
is aspartic acid, asparagine, or tyrosine, respectively. In
mammalian SCAP or yeast Ncr1p, substitution with aspar-
agine or aspartic acid produce dominant phenotypes, which
is likely due to the loss of specific protein–protein interac-
tions. A critical component of this homeostasis is the inter-
action of SCAP with ER retention proteins such as INSIG1
and INSIG2. Although there is no SCAP orthologue in
yeast, INSIG-like proteins are conserved (Hampton, R., per-
sonal communication). Although they have no reported mu-
Figure 8. Pathways of subcellular sphingolipid transport in yeast. 
Ceramide is synthesized in the ER and transported by vesicular-
dependent (1) and -independent (1a) pathways to the Golgi 
compartment. Conversion to complex sphingolipids (IPC, MIPC, and 
M(IP)2C) is followed by migration from the Golgi apparatus to the 
plasma membrane (2) or to vacuoles (3). In the sphingolipid recycling 
pathway, transport from the plasma membrane to vacuoles (4), or 
from vacuoles to the plasma membrane or the Golgi compartment  
(5 or 6), is selective between sphingolipids. Thus, in normal yeast, 
IPC accumulates in vacuoles, whereas M(IP)2C and to a lesser extent 
MIPC accumulate in the plasma membrane. In NCR1Y718D strains, 
recycling is disturbed such that MIPC and M(IP)2C accumulate in 
the vacuole. The sequestration of MIPC results in diminished M(IP)2C 
synthesis and up-regulation of biosynthesis of MIPC from IPC.Sphingolipid recycling in yeast | Malathi et al. 555
tant phenotype, it is tempting to speculate they may interact
with Ncr1p.
One model for the failure to identify an ncr1 null pheno-
type could be that the protein functions in a redundant path-
way for sphingolipid recycling. Accordingly, NCR1Y718D acts
as a dominant mutant that corrupts mutually redundant path-
ways of sphingolipid recycling, thus revealing a phenotype.
The manipulation of these bypass pathways would be obvious
targets to circumvent the transport defects and thus treat NP-C
disease. Interestingly, overexpression of certain Rab proteins
implicated in vesicular transport suppresses loss of NPC1
(Choudhury et al., 2002; Walter et al., 2003). Whether or not
this is an avenue to therapy remains to be determined; how-
ever, the identification of such bypass pathways in yeast and
humans will provide a significant step in this direction.
Materials and methods
General
Standard methods were used for yeast manipulation (Ausubel et al., 1998).
Yeast strains are isogenic with W303-1A (Thomas and Rothstein, 1989).
Cholesterol, ergosterol, and nystatin were added from stock solutions (5
and 2 mg/ml in 1:1, ethanol/tyloxapol [Sigma-Aldrich] and 10 mg/ml in
propylene glycol, respectively). Zaragosic acid (provided by Y.S. Chao,
Merck & Co., Rahway, NJ), sphingosine, C2-ceramide (BIOMOL Research
Laboratories, Inc.), and ABA (Panvera) were used at the concentrations in-
dicated. The BLAST alignment tool was used for sequence comparisons
(Altschul et al., 1997).
Mutagenesis of NCR1
NCR1 deletions were constructed by allele replacement (Erdeniz et al., 1997)
using a PCR product (oligos: 5  KONP’, 3  KONP) homologous to NCR1 at
its 5  and 3  ends and flanking the Kluyveromyces lactis URA3 gene. The lo-
cus was characterized by PCR with 5  and 3  NCR1 or URA3-specific oligos
(5 NPSCR, 006INTSCR, 3  NP-internal’, and 3 NPSCR). Missense alleles
were created similarly with oligos N25, D25, and C25 for the NCR1Y718N,
NCR1Y718D, and NCR1Y571C alleles, respectively. Ncr1p was tagged at the
COOH terminus with a triple HA epitope (18 residues) using a PCR-gener-
ated template (Schneider et al., 1995). All alleles were sequenced.
Expression of NCR1 in mammalian cells
NCR1 or NCR1-HA was amplified from yeast genomic DNA (oligos
5 NPSCR and 3 NPSCR) and incorporated into pCR3.1 digested with
EcoRV (pCR3.1-NCR1 and pCR3.1-NCR1-HA). The COOH-terminal 53
residues of NCR1 were replaced with amino acids 1214–1278 of human
NPC1 in pCR3.1-NCR1-Cterm after PCR amplification of the human
cDNA (5 NCR1tail-BsmI and 3 NPC1tail), digestion with BsmI and XhoI,
and ligation at the same sites in pCR3.1-NCR1.
CHO lines CT60 and NPC1-trap were cultured 3 d in Ham’s F12 and
10% lipoprotein-deficient serum and transfected (FuGENE 6; Roche Mo-
lecular Biochemicals) with pCR3.1, pCR3.1-NCR1, or pCR3.1-NCR1-
Cterm and a mammalian nuclear targeting-EGFP vector (Watari et al.,
1999) to identify transfected cells. Cells were incubated with 10% lipopro-
tein-deficient serum and 50  g/ml of human LDL for 24 h, fixed with 3%
PFA, and stained with 50  g/ml of filipin (Sigma-Aldrich). Cells were im-
aged by confocal fluorescence microscopy (model LSM510; Carl Zeiss Mi-
croImaging, Inc.; excitation 488 nm for EGFP). For quantitative analysis,
filipin-corrected cells were counted from multiple fields of EGFP-positive
cells. For detection of GM1, cells were washed with Ham’s F12, 25 mM
Hepes, pH 7.4, and 0.01% BSA, incubated with 20 nM of Alexa 555–con-
jugated CtxB (Molecular Probes, Inc.) for 1 h at 37 C, and fixed with 4%
PFA. Fluorescence images were collected after excitation at 568 nm using
an microscope (model Axiomat 100; Carl Zeiss MicroImaging, Inc.).
Phenotypic analyses
The expression of NCR1-HA was confirmed in Triton X-100–soluble pro-
tein extracts (Guo et al., 2001) by immunoblotting with the 12CA5 mAb
(Roche Molecular Biochemicals). Protein deglycosylation with endogly-
cosidase H was accomplished as directed (Roche Molecular Biochemi-
cals). For growth in the presence of sphingosine (in ethanol) or ABA (in
DMSO), cells were continuously monitored at 25 C at 600 nm using a mi-
crobiology reader (model Bioscreen C; ThermoLabsystems). BBL Gas Jars
and GasPak Plus (Becton Dickinson) were used for anaerobic experiments
(Tinkelenberg et al., 2000). Growth tests on 2% potassium acetate, 3% eth-
anol, 0.8 M calcium chloride, 0.75 M sodium chloride, C2-ceramide (in
0.1% ethanol/0.05% tergitol), or 40 mM hydroxyurea were performed on
solid YP media. Total RNA was isolated from independent isolates of the
ncr1  strain grown to OD600   0.5–0.6 in YEPD and analyzed in microar-
ray or northern hybridizations (Wilcox et al., 2002).
Cell labeling (10  Ci [
3H]acetic acid [NEN Life Science Products], 5.0
 Ci [
3H]oleic acid [NEN Life Science Products], or 2  Ci/ml [
3H]DHS
[American Radiolabeled Chemicals]; for 2–5 h), lysis, release of lipids,
TLC, and data collection were performed as described previously (Yang et
al., 1996). Sphingolipids were isolated from cells treated with 5% TCA
(ice, 15 min) by extraction with diethylether/ethanol/water/pyridine/am-
monia (5:15:15:1:0.18, vol/vol) for 60 min at 60 C, resuspension was per-
formed in chloroform/methanol/water (16:16:5) and TLC was performed
on silica gel 60 (EM Science) plates resolved with chloroform/methanol/
4.2N ammonia (9:7:2). Ergosterol localization was visualized by filipin
staining (20  g/ml) as above.
Membrane preparations from cells grown for 18 h in the presence of
[
3H]DHS, [
3H]acetic acid, or [
3H]oleic acid were subjected to discontinu-
ous gradient ultracentrifugation in Renografin-60 (Bracco Diagnostics;
Tinkelenberg et al., 2000). 250- l fractions were diluted 10-fold with Tris
EDTA buffer and centrifuged at 100,000 g. Radiolabeled sphingolipids
were extracted from the pellet and resolved by TLC as before. Marker pro-
teins for the ER (Dpm1p [dolichol phosphate mannose synthase]), vacuoles
(Vph1p [vacuolar H
 -ATPase]), and plasma membrane (Pma1p [plasma
membrane ATPase]; antisera provided by A. Chang, University of Michi-
gan, Ann Arbor, MI) indicated peak fractions for these organelles.
Online supplemental material
All oligonucleotides were synthesized by Invitrogen and are described in
Table S1. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200310046/DC1.
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